Non-Bacterial Thrombotic Endocarditis: A Presentation of COVID-19
- PMID: 32789144
- PMCID: PMC7417053
- DOI: 10.12890/2020_001811
Non-Bacterial Thrombotic Endocarditis: A Presentation of COVID-19
Abstract
The SARS-CoV-2 virus is a newly emergent pathogen first identified in Wuhan, China, and responsible for the COVID-19 global pandemic. In this case report we describe a manifestation of non-bacterial thrombotic endocarditis with continuous peripheral embolization in a COVID-19-positive patient. The patient responded well to high-dose LMWH treatment with cessation of the embolic process.
Learning points: Raising awareness of possible complications of COVID-19.To highlight the importance of the careful consideration of and dosage of anticoagulation in non-bacterial thrombotic endocarditis.
Keywords: COVID-19; Endocarditis; mitral valve; ultrasound.
© EFIM 2020.
Conflict of interest statement
Conflicts of Interests: The Authors declare that there are no competing interests.
Figures
References
-
- Bauer KA, Lawrence LK, Finlay G. Nonbacterial thrombotic endocarditis. [accessed 27 May 2020];UpToDate. 2019 Available at: https://www.uptodate.com/contents/nonbacterial-thrombotic-endocarditis.
LinkOut - more resources
Full Text Sources
Miscellaneous